in

Clinical stage immuno-oncology company: PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Corporation (NASDAQ: PDSB) was founded in 2009 and is headquartered in Berkeley Heights, New Jersey, USA, with 10 full-time employees. It is a clinical stage immuno-oncology company that develops multifunctional immunotherapy products.

PDS Biotechnology Corporation

PDS Biotechnology Corporation (PDSB):

PDS Biotechnology Corporation develops products for the treatment of early and late cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and other cancers.

The main product candidate of PDS Biotechnology Corporation is PDS0101, an immunotherapeutic drug used to treat cancer .

The lipid immunotherapy platform synthesized by PDS Biotechnology Corporation is Versamune. The company develops Versamune products for the treatment of cancer.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all Intels

Biopharmaceutical company: Cellular Biomedicine Group (CBMG)

Oil and gas company: Ring Energy, Inc. (REI)